Mostrar el registro sencillo del ítem

dc.contributor.authorMirón Rubio, Manuel
dc.contributor.authorParra Jordán, Juan José
dc.contributor.authorGonzález Ramallo, Víctor José
dc.contributor.authorMujal Martínez, Abel
dc.contributor.authorFernández Muixí, Josefina
dc.contributor.authorIglesias Gallego, Marina
dc.contributor.authorLucas Núñez, María Cruz
dc.contributor.authorRodado Alabau, Elisa
dc.contributor.authorVidal Perez-Campoamor, Sandra
dc.contributor.authorUría, Estefany
dc.date.accessioned2024-02-22T15:10:30Z
dc.date.available2024-02-22T15:10:30Z
dc.date.issued2023
dc.identifier.issn0214-3429spa
dc.identifier.urihttps://hdl.handle.net/10641/4078
dc.description.abstractObjective. To describe and quantify resource use and direct health costs associated with skin and skin structure infections (SSSIs) caused by Gram-positive bacteria in adults receiving outpatient parenteral antimicrobial therapy (OPAT), administered by Hospital at Home units (HaH) in Spain. Material and methods. Observational, multicenter, retrospective study. We included patients of both sexes included in the HaH-based OPAT Registry during 2011 to 2017 who were hospitalized due to SSSIs caused by Gram-positive bacteria. Resource use included home visits (nurses and physician), emergency room visits, conventional hospitalization stay, HaH stay and antibiotic treatment. Costs were quantified by multiplying the natural units of the resources by the corresponding unit cost. All costs were updated to 2019 euros. Results. We included 194 episodes in 189 patients from 24 Spanish hospitals. The most frequent main diagnoses were cellulitis (26.8%) and surgical wound infection (24.2%), and 94% of episodes resulted in clinical improvement or cure after treatment. The median HaH stay was 13 days (interquartile range [IR]:8-22.7), and the conventional hospitalization stay was 5 days (IR: 1-10.7). The mean total cost attributable to the complete infectious process was €7,326 (95% confidence interval: €6,316-€8,416). Conclusions. Our results suggest that OPAT administered by HaH is a safe and efficient alternative for the management of these infections and could lead to lower costs compared with hospital admission.spa
dc.language.isoengspa
dc.publisherRevista Española de Quimioterapiaspa
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectHospital at homespa
dc.subjectOutpatient parenteral antimicrobial therapyspa
dc.subjectCost analysisspa
dc.subjectSkin and skin structure infectionsspa
dc.titleEconomic burden of skin and skin structure infections due to Gram-positive bacteria in patients on hospital at home-based outpatient parenteral antibiotic therapy (OPAT).spa
dc.typejournal articlespa
dc.type.hasVersionAMspa
dc.rights.accessRightsopen accessspa
dc.description.extent540 KBspa
dc.identifier.doi10.37201/req/134.2022spa
dc.relation.publisherversionhttps://seq.es/abstract/rev-esp-quimioter-2023-april-5-4/spa


Ficheros en el ítem

FicherosTamañoFormatoVer
miron05apr2023.pdf539.3KbPDFVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 3.0 España